Advertisement

Special Considerations in the Evaluation of Alleged Sex Offenders

  • J. M. W. Bradford
Chapter
  • 66 Downloads
Part of the Critical Issues in American Psychiatry and the Law book series (CIAP, volume 5)

Abstract

There are various indications that sexual offenders demand intensive and urgent study. In the lay press, such recent reports as the allegations of sexual abuse at the Manhattan Beach preschool in California have alerted North American citizens to the very serious problem that exists. A national poll by the Los Angeles Times (1985) showed that between 10.9 and 17.6 million American men have sexually abused a child. It also showed that 27% of females and 16% of males were victims of a sexual assault.1 In Canada, the federal ministries of Justice and National Health and Welfare and the Attorney General of Canada established, in 1980, a committee on Sexual Offences Against Children and Youths. Commonly known as the Badgley Committee, it reported, in 1984, that one in two females and one in three males were victims of unwanted sexual acts on the basis of a Gallup survey. These acts included the whole spectrum of sexual activity from minor fondling to a sexually aggressive act such as rape.2 According to the study, 4 out of 100 young females are raped and 2 out of 100 are subjected to unwanted anal penetration.

Keywords

Sexual Arousal Sexual Offender Sexual Offence Violence Group Sexual Sadism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Timnick L: 22% in Survey Were Child Abuse Victims. Los Angeles Times, August 25, 1985, p 1.Google Scholar
  2. 2.
    Report of the Committee on Sexual Offences against Children and Youths: Sexual Offences Against Children in Canada: Summary: Ministry of Supply and Services, Ottawa, 1984, pp 1–2.Google Scholar
  3. 3.
    Abel GG, Becker JV, Murphy WD, et ai: Identifying dangerous child molesters, in Stuart R (ed): Violent Behavior: Social Learning Approaches to Prediction; Management and Treatment. New York, Brunner/Mazel, Inc 1981.Google Scholar
  4. 4.
    Abel GG, Mittelman M, Becker JV: Sexual offenders: Results of assessment and recommendations for treatment, in Ben-Aron MH, Hucker SJ, Webster CD (eds.): Clinical Criminology: Current Concepts. Toronto, M&M Graphics, 1985. Google Scholar
  5. 5.
    Bradford JMW, Boulet J, Pawlak A: The paraphilias: A multiplicity of deviant behaviours. Can J Psychiatry (accepted for publication).Google Scholar
  6. 6.
    Bancroft J: Human Sexuality and Its Problems. Edinburgh, Churchill Livingstone, 1983.Google Scholar
  7. 7.
    Le Maire L: Danish experiences regarding the castration of sexual offenders. J Crim Law Criminol Police Sci 1956; 47:295–310.Google Scholar
  8. 8.
    Ortmann J: The treatment of sexual offenders, castration and antihormone therapy. Int J Law Psychiatry 1980; 3:443–451.PubMedCrossRefGoogle Scholar
  9. 9.
    Heim N, Hursch CJ: Castration for sexual offenders: Treatment or punishment? A review and critique of recent European literature. Arch Sex Behav 1979; 8:281–304.PubMedCrossRefGoogle Scholar
  10. 10.
    Bradford JMW: Research on sex offenders, in Sadoff RL (ed): The Psychiatric Clinics of North America. Philadelphia, W.B. Saunders Co, 1983, pp 715–733.Google Scholar
  11. 11.
    Bradford JMW, McLean D: Sexual offenders, violence and testosterone: A clinical study. Can J Psychiatry 1984; 29:335–343.PubMedGoogle Scholar
  12. 12.
    Persky H, Smith KD, Basu GK: Relation of psychologic measures of aggression and hostility to testosterone production in man. Psychosom Med 1971; 33:265–277.PubMedGoogle Scholar
  13. 13.
    Kreuz LE, Rose RM: Assessment of aggressive behavior and plasma testosterone in a young criminal population. Psychosom Med 1972; 34:321–332.PubMedGoogle Scholar
  14. 14.
    Meyer-Bahlburg HFL, Nat R, Boon DA, et al: Aggressiveness and testosterone measures in man. Psychosom Med 1974; 36:269–274.PubMedGoogle Scholar
  15. 15.
    Ehrenkranz J, Bliss E, Sheard MH: Plasma testosterone: Correlation with aggressive behavior and social dominance in man. Psychosom Med 1974; 36:469–475.PubMedGoogle Scholar
  16. 16.
    Brown WA, Davis GH: Serum testosterone and irritability in man. Psychosom Med 1975; 37:87.Google Scholar
  17. 17.
    Rada RT, Laws DR, Kellner R: Plasma testosterone levels in the rapist. Psychosom Med 1976; 38:257–268.PubMedGoogle Scholar
  18. 18.
    Monti PM, Brown WA, Corriveau DD: Testosterone and components of aggressive and sexual behavior in man. Am J Psychiatry 1977; 134(6):692–694.PubMedGoogle Scholar
  19. 19.
    Olweus D, Mattsson A, Schalling D, et al: Testosterone, aggression, physical and personality dimensions in normal adolescent males.Psychosom Med 1980; 42:253–269.PubMedGoogle Scholar
  20. 20.
    Scaramella TJ, Brown WA: Serum testosterone and aggressiveness in hockey players. Psychosom Med 1978; 40:262–265.PubMedGoogle Scholar
  21. 21.
    Nielsen J: Gender role identity and sexual behaviour in persons with sex chromosome abberations. Dan Med Bull 1972; 17:269–275.Google Scholar
  22. 22.
    Hunter H: A controlled study of the psychopathology and physical measurements of Klinefelter’s syndrome. Br J Psychiatry 1969; 115:443–448.PubMedCrossRefGoogle Scholar
  23. 23.
    Schroder J, De La Chapelle A, Hakola P, et al: The frequency of XYY and XXY men among criminal offenders. Acta Psychiatr Scand 1981; 63:272–276.PubMedCrossRefGoogle Scholar
  24. 24.
    Money J, Annecello C, Van Orman B, et at: Cytogenetics, hormones and behavior disability: Comparison of XYY and XXY syndromes. Clin Genet 1974; 6:370–382. PubMedCrossRefGoogle Scholar
  25. 25.
    Baker P, Telfer MA, Richardson CE, et al: Chromosome errors in men with antisocial behavior.JAMA 1970; 214(5):869–878.PubMedCrossRefGoogle Scholar
  26. 26.
    Nielsen J: Criminality among patients with Klinefelter’s syndrome and the XYY syndrome.Br J Psychiatry 1970; 117:365–369.PubMedCrossRefGoogle Scholar
  27. 27.
    Wakeling A: Comparison study of psychiatric patients with Klinefelter’s syndrome and hypogonadism. Psychol Med 1972; 2:139–154.PubMedCrossRefGoogle Scholar
  28. 28.
    Crowley JT: Klinefelter’s syndrome and abnormal behavior: A case report. Int J Neuropsychiatry 1964; 5:359–363.Google Scholar
  29. 29.
    Pasqualine RQ, Vidal G, Bur GE: Psychopathology of Klinefelter’s syndrome: Review of 31 cases. Lancet 1957; 2:164–167.CrossRefGoogle Scholar
  30. 30.
    Beumont PJV, Bancroft JHJ, Beardwood CJ, et al: Behavioral changes after treatment with testosterone: Case report. Psychol Med 1972; 2:70–72.PubMedCrossRefGoogle Scholar
  31. 31.
    Dorner G: Sex-hormone-dependent brain differentiation and reproduction, in Money J, Musaph H (eds): Handbook of Sexology II, Genetics, Hormones and Behavior. New York, Elsevier North Holland, Inc, 1978.Google Scholar
  32. 32.
    Freund K: Diagnosing heterosexual pedophilia by means of a test for sexual interest. Behav Res Ther 1965; 3:229–234.PubMedCrossRefGoogle Scholar
  33. 33.
    Freund K: Diagnosing homo- or heterosexuality and erotic age-preference by means of a psychophysiological test. Behav Res Ther 1967; 5:209–228.PubMedCrossRefGoogle Scholar
  34. 34.
    Freund K: Erotic preference in pedophilia. Behav Res Ther 1967; 5:339–348.CrossRefGoogle Scholar
  35. 35.
    Abel GG, Blanchard EB, Barlow DM: Measurement of sexual arousal in several paraphilias: The effects of stimulus modality, instructional set and stimulus content on the objective. Behav Res Ther 1981; 19:25–33.PubMedCrossRefGoogle Scholar
  36. 36.
    Abel GG, Blanchard EB, Becker JV, et al: Differentiating sexual aggressives with penile measures. Crim Just Behav 1978; 5:315–332.CrossRefGoogle Scholar
  37. 37.
    Barbaree HE, Marshall WL, Lanthier RD: Deviant arousal in rapists.Behav Res Ther 1979; 17:252–259.CrossRefGoogle Scholar
  38. 38.
    Abel GG, Barlow DH, Blanchard EB, et ai: The components of rapists’ sexual arousal. Arch Gen Psychiatry 1977; 34:895–903.PubMedGoogle Scholar
  39. 39.
    Stuart RB (ed.): Violent Behavior: Social Learning Approaches to Prediction, Management and Treatment. New York, Brunner/Mazel Inc, 1981. Google Scholar
  40. 40.
    Laws DR, Rubin HB: Instructional control of an autonomic response. J Appl Behav Anal 1969; 2:93–99.PubMedCrossRefGoogle Scholar
  41. 41.
    Freund K, Chan S, Coulthard R: Phallometric diagnosis with “nonadmitters.” Behav Res Ther 1979; 17:451–457.PubMedCrossRefGoogle Scholar
  42. 42.
    Farkas GM, Evans IM, Sine LF, et al: Reliability and validity of the mercury-in-rubber strain gauge measure of penile circumference. Behav Ther 1979; 10:555–561.CrossRefGoogle Scholar
  43. 43.
    Wincze JP, Venditti E, Barlow D, et al.: The effects of a subject monitoring task in the physiological measure of genital response to erotic stimulation. Arch Sex Behav 1980; 9:533–545.PubMedCrossRefGoogle Scholar
  44. 44.
    Farkas GM, Evans IM, Sine LF et al: Reliability and validity of the mercury-in-rubber strain gauge measure of penile circumference. Behav Ther 1979; 10:557.CrossRefGoogle Scholar
  45. 45.
    Derogatis LR: Psychological assessment of psychosexual functioning, in Meyer JK (ed): The Psychiatric Clinics of North America Philadelphia, W.B. Saunders Company, 1980. Google Scholar
  46. 46.
    Masters WH, Johnson VE: Human Sexual Inadequacy. Boston, Little, Brown & Co, 1970. Google Scholar
  47. 47.
    Bradford JMW, Pawlak A: Sadistic homosexual pedophilia: Treatment with cyproterone acetate a single case study. Can J Psychiatry 1987; 32:22–31.PubMedGoogle Scholar
  48. 48.
    Foote RM: Diethylstilbestrol in the management of psychopathological states in males. J Nerv Ment Dis 1944; 99:928–935.CrossRefGoogle Scholar
  49. 49.
    Golla FL, Hodge SR: Hormone treatment of sexual offenders. Lancet 1949; 1:1006–1007.PubMedCrossRefGoogle Scholar
  50. 50.
    Whittaker LH: Oestragens and psychosexual disorders. Med J Aust 1959; 2:547–549.Google Scholar
  51. 51.
    Heller CG, Laidlaw WM, Harvey HT, et al: Effects of progestational compounds on the reproductive processes of the human male. Ann NY Acad Sci 1958; 71:649–655.PubMedCrossRefGoogle Scholar
  52. 52.
    Money J: Use of androgen depleting hormone in the treatment of male sex offenders. J Sex Res 1970; 6:165–172.CrossRefGoogle Scholar
  53. 53.
    Money JM, Wiedeking C, Walker PA, et al: Combined antiandrogen and counselling program for treatment of 46, XY and 47, XYY sex offenders, in Sachar E (ed): Hormones, Behavior and Psychopathology. New York, Raven Press, 1976, pp 105–120.Google Scholar
  54. 54.
    Wiedeking C, Money J, Walker PA: Follow up 11 XYY males with impulsive and/or sex-offending behavior. Psychol Med 1979; 9:287–292.PubMedCrossRefGoogle Scholar
  55. 55.
    Walker PA, Meyer WJ: Medroxyprogesterone acetate treatment for paraphiliac sex offenders, in Hays JR, Roberts TK, Solway KS (eds): Violence and the Violent Individual. New York, S.P. Medical and Scientific Books, 1981, pp 353–373.Google Scholar
  56. 56.
    Gagne P: Treatment of sex offenders with medroxyprogesterone acetate. Am J Psychiatry 1981; 138:644–646.PubMedGoogle Scholar
  57. 57.
    Berlin FS, Meinecke CF: Treatment of sex offenders with antiandrogenic medication: Conceptualization, review of treatment modalities, and preliminary findings. Am J Psychiatry 1981; 138:601–607.PubMedGoogle Scholar
  58. 58.
    Southren AL, Gordon GG, Vittek J, et al: Effect of progestagens on androgen metab-olism, in Martini L, Motta M (eds): Androgens and Antiandrogens. New York, Raven Press, 1977, pp 263–279.Google Scholar
  59. 59.
    Liang T, Tymoczko JL, Chan KMB, et al: Androgen action: Receptors and rapid responses, in Martini L, Motta M (eds): Androgens and Antiandrogens. New York, Raven Press, 1977, pp 77–89.Google Scholar
  60. 60.
    Mainwaring IP: Modes of action of antiandrogens: A survey, in Martini L, Motta M (eds): Androgens and antiandrogens. New York, Raven Press, 1977, pp 151–161.Google Scholar
  61. 61.
    Chapman MG: Side effects of antiandrogen therapy, in Jeffcoate SL (ed): Androgens and Anti-androgen Therapy. New York, John Wiley & Sons, 1982, pp 169–178.Google Scholar
  62. 62.
    Laschet U, Laschet L: Antiandrogens in the treatment of sexual deviations of men.J Steroid Biochem 1975; 6:821–826. PubMedCrossRefGoogle Scholar
  63. 63.
    Neumann F: Pharmacology and potential use of cyproterone acetate. Horm Metab Res 1977; 9:1–13.PubMedCrossRefGoogle Scholar
  64. 64.
    Cremonocini C, Vignati E, Libroia A: Treatment of hirsutism and acne in woman with two combinations of cyproterone acetate and ethinylestradiol. Acta Eur Fertil 1976; 7:299–314.Google Scholar
  65. 65.
    Bradford JMW, Pawlak A: Double-blind placebo crossover study of cyproterone acetate in the treatment of sexual deviation. Can J Psychiatry (accepted for publication).Google Scholar
  66. 66.
    Laschet U, Laschet L: Psychopharmacotherapy of sex offenders with cyproterone acetate. Pharmakopsychatr Neuropsychopharmakol 1971; 4:99–104.Google Scholar
  67. 67.
    Ott F, Hoffet H: The influence of antiandrogens on libido, potency and testicular function. Schweiz Med Wochenschr 1968; 98:1812–1815.PubMedGoogle Scholar
  68. 68.
    Mothes C, Lehnert J, Samimi F, et ai: Schering Symposium über Sexual Deviationen und ihre medikamentöse Behandlung. Life Sei Monog 1971; 2:65.Google Scholar
  69. 69.
    Cooper AJ, Ismail AA, Phanjoo AL, et al.: Antiandrogen (cyproterone acetate) therapy in deviant hypersexuality. Br J Psychiatry 1972; 120:59–63.PubMedCrossRefGoogle Scholar
  70. Bancroft J, Tennent G, Loucas K, et al: The control of deviant sexual behaviour by drugs: 1.Behavioral changes following oestrogens and anti-androgens. Br J Psychiatry 1974; 125:310–315. PubMedCrossRefGoogle Scholar
  71. 71.
    Murray MAF, Bancroft JHJ, Anderson DC, et al: Endocrine changes in male sexual deviants after treatment with antiandrogens, oestrogens or tranquilizers. J Endocrinol 1975; 67:179–188.PubMedCrossRefGoogle Scholar
  72. 72.
    Davies TD: Cyproterone acetate for male hypersexuality. J Int Med Res 1974; 2:159–163.PubMedGoogle Scholar
  73. 73.
    Cooper AJ: A placebo controlled study of the antiandrogen cyproterone acetate in deviant hypersexuality. Compr Psychiatry 1981; 22:458–464.Google Scholar
  74. 74.
    Marshall WL: The modification of sexual fantasies: A combined treatment approach to the reduction of deviant sexual behavior. Behav Res Ther 1973; 11:557-564.Google Scholar
  75. 75.
    Marshall WL, Barbaree HL: The reduction of deviant arousal: Satiation treatment for sexual aggressors. Crim Just Behav 1978; 5:294-303.Google Scholar
  76. 76.
    Abel GG, Blanchard EB, Becker JV: An integrated treatment program for rapists, in Rada R (ed): Clinical Aspects of the Rapists. New York, Grune & Stratton Inc, 1977, pp 161-214.Google Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • J. M. W. Bradford
    • 1
    • 2
  1. 1.Department of Psychiatry, Faculty of Health SciencesUniversity of OttawaOttawaCanada
  2. 2.Forensic Psychiatry and the Sexual Behaviors ClinicRoyal Ottawa HospitalOttawaCanada

Personalised recommendations